RxDoctor Payments Data

John Zuniga, DDS

Oral and Maxillofacial Surgery · Dallas, TXNPI 1588660856

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (50.8%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Axogen accounts for 96.3% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $39,290 and has fallen 98.0% since, to $797 in 2025. Among oral and maxillofacial surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$60,660in general payments, 2019–2025

Across 99 payments — averaging $612.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axogen$58K
  • Kls-martin L.p.$1K
  • Zimmer Biomet$373
  • Johnson & Johnson$249
  • Checkpoint Surgical, Inc$145
  • Vertex$38
  • plus $110 from 5 others

What the payments were for

  • Consulting fees$18,02530%
  • Speaking & faculty fees$30,82951%
  • Travel & lodging$3,6296%
  • Food & beverage$8,17713%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$60,660 in reported general payments places this provider in the 95th percentile of 591 oral and maxillofacial surgery providers in Texas.

See all oral and maxillofacial surgery providers in Texas

Medicare billing

Part B allowed, 2024
$23,587
Medicare patients
98
Services billed
193

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Carbamazepine44$1,477
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen27$263
Gabapentin17$227
Tizanidine Hcl12$20

Paid to pharmacies, not to this prescriber.

Other oral and maxillofacial surgery in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →